Lionel Hebbard

This study evaluates the antioxidant, anti-inflammatory, and antiproliferative activities of extracts from seven Australian Indigenous medicinal plants, finding distinct bioactivities with potential relevance to anticancer drug discovery.

This study benchmarks fusion detection methods using long-read RNA sequencing, finding that ONT PCR-cDNA with CTAT-LR-Fusion offers the best balance of precision and recall.

This paper validates the TARGET-SL framework for predicting genetic events and drug sensitivities in liver cancer using cell lines and patient-derived organoids, showing potential to improve personalized drug screening.